Literature DB >> 15618854

Subfulminant liver failure associated with quetiapine.

Ihab El Hajj1, Ala I Sharara, Don C Rockey.   

Abstract

We report the clinical history of a patient with drug induced liver injury due to quetiapine who ultimately developed subfulminant hepatic failure and died. The clinical presentation, laboratory data, as well as liver histopathology were supportive of the putative diagnosis of drug induced liver injury. To our knowledge, this is the first report of the important association between quetiapine and drug induced liver injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15618854     DOI: 10.1097/00042737-200412000-00029

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

Review 1.  Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.

Authors:  Mahmoud Slim; Inmaculada Medina-Caliz; Andres Gonzalez-Jimenez; M Rosario Cabello; Fermin Mayoral-Cleries; M Isabel Lucena; Raul J Andrade
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

Review 2.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Safety Assessment of Liver Injury with Quetiapine Fumarate XR Management in Very Heavy Drinking Alcohol-Dependent Patients.

Authors:  Vatsalya Vatsalya; Akash Pandey; Melanie L Schwandt; Matthew C Cave; Shirish S Barve; Vijay A Ramchandani; Craig J McClain
Journal:  Clin Drug Investig       Date:  2016-11       Impact factor: 2.859

4.  Fulminant hepatic failure in association with quetiapine: a case report.

Authors:  Fawaz Al Mutairi; Girish Dwivedi; Turki Al Ameel
Journal:  J Med Case Rep       Date:  2012-12-12

5.  Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study.

Authors:  Joseph F Hayes; Louise Marston; Kate Walters; John R Geddes; Michael King; David P J Osborn
Journal:  PLoS Med       Date:  2016-08-02       Impact factor: 11.069

Review 6.  Liver Illness and Psychiatric Patients.

Authors:  Paul Carrier; Marilyne Debette-Gratien; Murielle Girard; Jérémie Jacques; Philippe Nubukpo; Véronique Loustaud-Ratti
Journal:  Hepat Mon       Date:  2016-12-03       Impact factor: 0.660

Review 7.  Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.

Authors:  Diogo Telles-Correia; António Barbosa; Helena Cortez-Pinto; Carlos Campos; Nuno B F Rocha; Sérgio Machado
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06

Review 8.  Antidepressants- and antipsychotics-induced hepatotoxicity.

Authors:  Nevena Todorović Vukotić; Jelena Đorđević; Snežana Pejić; Neda Đorđević; Snežana B Pajović
Journal:  Arch Toxicol       Date:  2021-01-05       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.